- /
- Supported exchanges
- / US
- / NXL.NASDAQ
Nexalin Technology Inc. (NXL NASDAQ) stock market data APIs
Nexalin Technology Inc. Financial Data Overview
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Nexalin Technology Inc. data using free add-ons & libraries
Get Nexalin Technology Inc. Fundamental Data
Nexalin Technology Inc. Fundamental data includes:
- Net Revenue: 217 K
- EBITDA: -9 080 485
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-12
- EPS/Forecast: -0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Nexalin Technology Inc. News
New
ASX Value Stock Picks Including Capricorn Metals And Two Others Estimated Below Intrinsic Value
The Australian market is currently experiencing a positive shift, with shares advancing on the news of a potential peace agreement between Iran and the U.S., which has traders optimistic about stabili...
Kina Securities And 2 Other Stocks That May Be Trading Below Their Estimated Value On The ASX
In the midst of a challenging period for Australian shares, with market sentiment swayed by geopolitical tensions and economic uncertainties, investors are increasingly on the lookout for opportunitie...
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
Newly issued U.S. patent expected to provide core intellectual property protection through 2042, further strengthening Nexalin’s proprietary position in non-invasive frequency-based deep-brain neuro...
ASX Stocks That Could Be Trading Below Their Estimated Value
As the Australian market shows signs of a cautious rise amid economic cooling and upcoming financial year-end factors, investors are keenly observing how these conditions might influence stock valuati...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.